{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:35:12Z","timestamp":1775104512868,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["No.62402297"],"award-info":[{"award-number":["No.62402297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["No.62372280"],"award-info":[{"award-number":["No.62372280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["No.82205198"],"award-info":[{"award-number":["No.82205198"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["No. ZR2022QG051"],"award-info":[{"award-number":["No. ZR2022QG051"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Fund Project of Shandong University of Chinese Medicine","award":["No.KYRW2024Q04"],"award-info":[{"award-number":["No.KYRW2024Q04"]}]},{"name":"Science and Technology of Traditional Chinese Medicine Project of Shandong Province","award":["No. Q-2023045"],"award-info":[{"award-number":["No. Q-2023045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04734-3","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:45:09Z","timestamp":1763538309000},"page":"6127-6143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patent analysis of mRNA therapy using deep learning"],"prefix":"10.1007","volume":"399","author":[{"given":"Yuanqi","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huali","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benzheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"4734_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jconrel.2022.11.042","volume":"353","author":"V Andretto","year":"2023","unstructured":"Andretto V, Repellin M, Pujol M (2023) Hybrid core-shell particles for mRNA systemic delivery. J Control Release 353:1037\u20131049. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.042","journal-title":"J Control Release"},{"key":"4734_CR2","unstructured":"Arbutus (2018) Arbutus Settles Litigation, Terminating Acuitas\u2019 Rights.to LNP Technology. https:\/\/investor.arbutusbio.com\/news-releases\/news-release-details\/arbutus-settles-litigation-terminating-acuitas-rights-lnp-0. Accessed 1 Dec 2022"},{"issue":"5","key":"4734_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/bit.21493","volume":"98","author":"ER Arulmuthu","year":"2007","unstructured":"Arulmuthu ER, Williams DJ, Baldascini H (2007) Studies on aerosol delivery of plasmid DNA using a mesh nebulizer. Biotechnol Bioeng 98(5):939\u2013955. https:\/\/doi.org\/10.1002\/bit.21493","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"4734_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier AJ, Jiang AYJ, Zhang P (2022) The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol 40(6):840\u2013854. https:\/\/doi.org\/10.1038\/s41587-022-01294-2","journal-title":"Nat Biotechnol"},{"key":"4734_CR5","unstructured":"Biotech R (2021) LNP patents, a pain point for the mRNA pharmaceutical industry. http:\/\/www.rc-rna.com\/cn\/home\/news\/id\/957. Accessed 26 Nov 2022"},{"issue":"4776","key":"4734_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/190576a0","volume":"190","author":"S Brenner","year":"1961","unstructured":"Brenner S, Jacob F, Meselson M (1961) An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 190(4776):576\u2013581","journal-title":"Nature"},{"key":"4734_CR7","doi-asserted-by":"publisher","unstructured":"Buschmann MD, Carrasco MJ, Alishetty S et al (2021) Nanomaterial delivery systems for mRNA vaccines. Vaccines. https:\/\/doi.org\/10.3390\/vaccines9010065","DOI":"10.3390\/vaccines9010065"},{"issue":"11","key":"4734_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Weissman D, Whitehead KA (2021) MRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 20(11):817\u2013838. https:\/\/doi.org\/10.1038\/s41573-021-00283-5","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"4734_CR9","doi-asserted-by":"publisher","first-page":"21546","DOI":"10.1021\/acsami.4c00793","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Deng Y, Li Y (2024) Oxygen-independent radiodynamic therapy: radiation-boosted chemodynamics for reprogramming the tumor immune environment and enhancing antitumor immune response. ACS Appl Mater Interfaces 16(17):21546\u201321556. https:\/\/doi.org\/10.1021\/acsami.4c00793","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"4734_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Wei T, Farbiak L et al (2020) Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-specific mRNA delivery. Nanotechnol 15(4):313\u2013320. https:\/\/doi.org\/10.1038\/s41565-020-0669-6","journal-title":"Nanotechnol"},{"issue":"33","key":"4734_CR11","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.2174\/0109298673309489240816063313","volume":"32","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Wang L, Zhang S et al (2024) The investigation of Nftiginhibitors to block cell proliferation in OSCC cells lines. Curr Med Chem 32(33):7314\u20137326. https:\/\/doi.org\/10.2174\/0109298673309489240816063313","journal-title":"Curr Med Chem"},{"key":"4734_CR12","unstructured":"China F (2021) Traceability of mRNA vaccine delivery technology: a tug-of-war over science, patents, and wealth. https:\/\/www.forbeschina.com\/business\/56943. Accessed 3 Jan 2023"},{"issue":"1","key":"4734_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1039\/D2NH00289B","volume":"8","author":"S Chung","year":"2023","unstructured":"Chung S, Lee CM, Zhang MQ (2023) Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases. Nanoscale Horiz 8(1):10\u201328. https:\/\/doi.org\/10.1039\/D2NH00289B","journal-title":"Nanoscale Horiz"},{"issue":"35","key":"4734_CR14","first-page":"34","volume":"96","author":"R Cross","year":"2018","unstructured":"Cross R (2018) Can mRNA disrupt the drug industry? Chem Eng News 96(35):34\u201340","journal-title":"Chem Eng News"},{"key":"4734_CR15","unstructured":"Delivery D (2022) Explains the origin and patent dispute of LNP as a drug delivery technology. https:\/\/mp.weixin.qq.com\/s\/J98ZKU4h_s8QBgsC670WbA. Accessed 3 Jan 2023"},{"key":"4734_CR16","doi-asserted-by":"publisher","unstructured":"Deng ZY, Tian YY, Song JX (2022) mRNA vaccines: the dawn of a new era of cancer immunotherapy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.887125","DOI":"10.3389\/fimmu.2022.887125"},{"key":"4734_CR17","doi-asserted-by":"publisher","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ (2021) On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2109256118","DOI":"10.1073\/pnas.2109256118"},{"key":"4734_CR18","unstructured":"Erhardt S. (2024) Automated patent landsca. CEUR-WS.org. https:\/\/ceur-ws.org\/Vol-3775\/paper8.pdf. Accessed 3 Oct 2025"},{"key":"4734_CR19","doi-asserted-by":"publisher","unstructured":"Fabris D (2020) From the PHOSITA to the MOSITA: will -leader-moderna-not-aware-of-any-significant-intellectual-property-impediments-in-development-of-its-vaccine. 51(6):685\u2013708. https:\/\/doi.org\/10.1007\/s40319-020-00953-8","DOI":"10.1007\/s40319-020-00953-8"},{"issue":"5","key":"4734_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/pharmaceutics16050684","volume":"16","author":"AG Fedorovskiy","year":"2024","unstructured":"Fedorovskiy AG, Antropov DN, Dome AS et al (2024) Novel efficient lipid-based delivery systems enable a delayed uptake and sustained expression of mRNA in human cells and mouse tissues. Pharmaceutics 16(5):684. https:\/\/doi.org\/10.3390\/pharmaceutics16050684","journal-title":"Pharmaceutics"},{"key":"4734_CR21","unstructured":"Gao F (2021) Report on the 3rd world science and technology development forum. WEFO. https:\/\/www.wfeo.org\/report-on-the-3rd-world-science-and-technology-development-forum\/. Accessed 3 Oct 2025"},{"issue":"5","key":"4734_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41587-021-00912-9","volume":"39","author":"M Gaviria","year":"2021","unstructured":"Gaviria M, Kilic B (2021) A network analysis of COVID-19 mRNA vaccine patents. Nat Biotechnol 39(5):546\u2013548. https:\/\/doi.org\/10.1038\/s41587-021-00912-9","journal-title":"Nat Biotechnol"},{"key":"4734_CR23","unstructured":"Haversack D, Shores D (2020) COVID-19 vaccine leader Moderna \u201cNot Aware of Any Significant Intellectual Property Impediments\u201d in development of its vaccine despite mixed results at PTAB. https:\/\/www.ptablaw.com\/2020\/11\/16\/covid-19-vaccine-leader-moderna-not-aware-of-any-significant-intellectual-property-impediments-in-development-of-its-vaccine-despite-mixed-results-at-ptab\/. Accessed 1 Oct 2025"},{"key":"4734_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett KJ, Benenato KE, Jacquinet E (2019) Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol Ther 15:1\u201311. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.013","journal-title":"Mol Ther"},{"issue":"2","key":"4734_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Kariko","year":"2005","unstructured":"Kariko K, Buckstein M, Ni HP (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23(2):165\u2013175. https:\/\/doi.org\/10.1016\/j.immuni.2005.06.008","journal-title":"Immunity"},{"issue":"11","key":"4734_CR26","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Kariko","year":"2008","unstructured":"Kariko K, Muramatsu H, Welsh FA (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16(11):1833\u20131840. https:\/\/doi.org\/10.1038\/mt.2008.200","journal-title":"Mol Ther"},{"issue":"4","key":"4734_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","volume":"12","author":"LA Keller","year":"2022","unstructured":"Keller LA, Merkel O, Popp A (2022) Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res 12(4):735\u2013757. https:\/\/doi.org\/10.1007\/s13346-020-00891-5","journal-title":"Drug Deliv Transl Res"},{"key":"4734_CR28","unstructured":"Kilpatrick Townsend (2025) COVID-19 vaccine patent war: Moderna\u2019s claims invalidated by PTAB. https:\/\/ktslaw.com\/en\/insights\/alert\/2025\/3\/covid%2019%20vaccine%20patent%20war%20moderna%20claims%20invalidated%20by%20ptab. Accessed 1 Sept 2025"},{"issue":"7607","key":"4734_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz LM, Diken M, Haas H et al (2016) Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534(7607):396. https:\/\/doi.org\/10.1038\/nature18300","journal-title":"Nature"},{"key":"4734_CR30","doi-asserted-by":"publisher","unstructured":"Krishtel P, Malpani R (2021) Suspend intellectual property rights for COVID-19 vaccines. BMJ 373:n1344. https:\/\/doi.org\/10.1136\/bmj.n1344","DOI":"10.1136\/bmj.n1344"},{"issue":"11","key":"4734_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41551-020-00623-7","volume":"4","author":"M Krohn-Grimberghe","year":"2020","unstructured":"Krohn-Grimberghe M, Mitchell MJ, Schloss MJ (2020) Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche. Nat Biomed Eng 4(11):1076. https:\/\/doi.org\/10.1038\/s41551-020-00623-7","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"4734_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1021\/acsptsci.3c00047","volume":"6","author":"D Li","year":"2023","unstructured":"Li D, Liu C, Li Y et al (2023) Messenger RNA-based therapeutics and vaccines: what\u2019s beyond COVID-19? ACS Pharmacol Transl Sci 6(7):943\u2013969. https:\/\/doi.org\/10.1021\/acsptsci.3c00047","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"4734_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","volume":"5","author":"S Ling","year":"2021","unstructured":"Ling S, Yang S, Hu X et al (2021) Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nat Biomed Eng 5(2):144\u2013156. https:\/\/doi.org\/10.1038\/s41551-020-00656-y","journal-title":"Nat Biomed Eng"},{"key":"4734_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jconrel.2020.06.027","volume":"325","author":"G Lou","year":"2020","unstructured":"Lou G, Anderluzzi G, Schmidt ST (2020) Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: the impact of cationic lipid selection. J Control Release 325:370\u2013379. https:\/\/doi.org\/10.1016\/j.jconrel.2020.06.027","journal-title":"J Control Release"},{"issue":"9","key":"4734_CR35","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s00204-024-03803-5","volume":"98","author":"H Ma","year":"2024","unstructured":"Ma H, Huang S, Li F (2024) Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy. Arch Toxikol 98(9):3049\u20133061. https:\/\/doi.org\/10.1007\/s00204-024-03803-5","journal-title":"Arch Toxikol"},{"key":"4734_CR36","unstructured":"Maier M, Jayaraman M, Akinc A, Matsuda S, Kandasamy P, Kallanthottathil R, Manoharan M, Inventor; Alnylam Pharmaceuticals Inc, assignee (2012) Biodegradable lipids for the delivery of active agents patent US11382979B2. Google Patents. https:\/\/patentimages.storage.googleapis.com\/08\/db\/bf\/c5a1495a725cf8\/US11382979.pdf. Accessed 3 Oct 2025"},{"issue":"9","key":"4734_CR37","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/d41573-020-00119-8","volume":"19","author":"C Martin","year":"2020","unstructured":"Martin C, Lowery D (2020) mRNA vaccines: intellectual property landscape. Nat Rev Drug Discov 19(9):578\u2013578","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4734_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","volume":"27","author":"G Maruggi","year":"2019","unstructured":"Maruggi G, Zhang CL, Li JW et al (2019) mRNA as a transformative technology for vaccine development to control infectious diseases. Mol Ther 27(4):757\u2013772. https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.020","journal-title":"Mol Ther"},{"issue":"6","key":"4734_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/10611869808997870","volume":"5","author":"S Mathison","year":"1998","unstructured":"Mathison S, Nagilla R, Kompella UB (1998) Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? J Drug Target 5(6):415\u2013441","journal-title":"J Drug Target"},{"key":"4734_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.addr.2014.05.018","volume":"75","author":"OM Merkel","year":"2014","unstructured":"Merkel OM, Rubinstein I, Kissel T (2014) SiRNA delivery to the lung: what\u2019s new? Adv Drug Deliv Rev 75:112\u2013128","journal-title":"Adv Drug Deliv Rev"},{"key":"4734_CR41","doi-asserted-by":"publisher","unstructured":"Miao L, Lin JQ, Huang YX et al (2020) Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-16248-y","DOI":"10.1038\/s41467-020-16248-y"},{"key":"4734_CR42","doi-asserted-by":"publisher","unstructured":"Miao L, Zhang Y, Huang L (2021) mRNA vaccine for cancer immunotherapy. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-021-01335-5","DOI":"10.1186\/s12943-021-01335-5"},{"key":"4734_CR43","unstructured":"National Development and Reform Commission (NDRC) (2016) The thirteenth five-year plan for national economic and social development of the People\u2019s Republic of China. https:\/\/en.ndrc.gov.cn\/policies\/202105\/P020210527785800103339.pdf. Accessed 3 Oct 2025"},{"key":"4734_CR44","unstructured":"Organization WH (2021) Moderna coronavirus disease 2019 (COVID-19) vaccine (messenger ribonucleic acid 1273) (mRNA-1273). World Health Organization. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/act-accelerator\/covax\/21081_chinese_moderna-vaccine-explainer.pdf?sfvrsn=7cee8939_5. Accessed 25 June 2024"},{"key":"4734_CR45","unstructured":"Organization WH (2025) mRNA technology transfer (mRNA TT) programme. World Health Organization. https:\/\/www.who.int\/initiatives\/mrna-technology-transfer-(mrna-tt)-programme. Accessed 1 Sept 2025"},{"key":"4734_CR46","unstructured":"Pfizer (2021) Financial performance. https:\/\/www.pfizer.com\/sites\/default\/files\/investors\/financial_reports\/annual_reports\/2021\/files\/Pfizer_Performance_Annual_Review.pdf. Accessed 13 Dec 2022"},{"issue":"11","key":"4734_CR47","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner E, Yang R, Foo KS (2022) Unlocking the promise of mRNA therapeutics. Nat Biotechnol 40(11):1586\u20131600. https:\/\/doi.org\/10.1038\/s41587-022-01491-z","journal-title":"Nat Biotechnol"},{"key":"4734_CR48","unstructured":"Rothwell F, Ernst Manbeck PC (2022) Arbutus and Genevant sue Moderna in first significant patent infringement lawsuit in the mRNA space https:\/\/www.jdsupra.com\/legalnews\/arbutus-and-genevant-sue-moderna-in-8835492\/. Accessed 3 Jan 2023"},{"issue":"6576","key":"4734_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik JG, Tombacz I, Yadegari A et al (2022) CAR T cells produced in vivo to treat cardiac injury. Science 375(6576):91. https:\/\/doi.org\/10.1126\/science.abm0594","journal-title":"Science"},{"issue":"10","key":"4734_CR50","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin U, Karik\u00f3 K, T\u00fcreci \u00d6 (2014) mRNA-based therapeutics--developing a new class of drugs. Nat Rev Drug Discov 13(10):759\u2013780. https:\/\/doi.org\/10.1038\/nrd4278","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4734_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.2042-7158.1995.tb05814.x","volume":"47","author":"T Sakane","year":"1995","unstructured":"Sakane T, Akizuki M, Taki Y (1995) Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J Pharm Pharmacol 47(5):379\u2013381. https:\/\/doi.org\/10.1111\/j.2042-7158.1995.tb05814.x","journal-title":"J Pharm Pharmacol"},{"key":"4734_CR52","unstructured":"Shores D, Tian V, Wang S (2022) mRNA patent and competitive landscape: 2021 year in review and 2022 outlook. https:\/\/www.rfemerge.com\/2022\/01\/03\/mrna-patent-and-competitive-landscape-2021-in-review-and-2022-outlook\/. Accessed 3 Oct 2025"},{"key":"4734_CR53","doi-asserted-by":"crossref","unstructured":"Singh S, Singh A (2023) Intellectual property rights and artificial intelligence: contemporary convergence and probable challenges. In: 2023 10th IEEE Uttar Pradesh Section Int Conf Electr Electron Comput Eng (UPCON), vol 10. IEEE, pp 1279\u20131286","DOI":"10.1109\/UPCON59197.2023.10434754"},{"key":"4734_CR54","unstructured":"StemiRNA (2022) LPP nanodelivery platform. https:\/\/www.stemirna.com\/lpp\/index.aspx. Accessed 20 Dec 2022"},{"issue":"6","key":"4734_CR55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3923\/ijp.2024.1051.1062","volume":"20","author":"C Sui","year":"2024","unstructured":"Sui C, Xia P, Sui J et al (2024) USP9X\/HOXA1 contributes to the cisplatin-resistentance of oral squamous cell carcinoma in vitro and in vivo. Int J Pharmacol 20(6):1051\u20131062. https:\/\/doi.org\/10.3923\/ijp.2024.1051.1062","journal-title":"Int J Pharmacol"},{"key":"4734_CR56","doi-asserted-by":"crossref","unstructured":"Sun X, Li X, Li J et al (2023) Text classification via large language models. arxiv preprint arxiv:2305.08377. https:\/\/arxiv.org\/pdf\/2305.08377. Accessed 1 Sept 2025","DOI":"10.18653\/v1\/2023.findings-emnlp.603"},{"key":"4734_CR57","doi-asserted-by":"publisher","unstructured":"Tang ZC, Qu Q, Teng XQ (2023) Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer. Front Pharmacol 14:1192855. https:\/\/doi.org\/10.3389\/fphar.2023.1192855","DOI":"10.3389\/fphar.2023.1192855"},{"key":"4734_CR58","doi-asserted-by":"crossref","unstructured":"Thambisetty S, McMahon A, McDonagh L et al (2021) The trips intellectual property waiver proposal: creating the right incentives in patent law and politics to end the COVID-19 pandemic. https:\/\/ssrn.com\/abstract=3851737. Accessed 1 Sept 2025","DOI":"10.2139\/ssrn.3851737"},{"issue":"4","key":"4734_CR59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/vaccines9040359","volume":"9","author":"TTH Thi","year":"2021","unstructured":"Thi TTH, Suys EJA, Lee JS et al (2021) Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines 9(4):359. https:\/\/doi.org\/10.3390\/vaccines9040359","journal-title":"Vaccines"},{"issue":"12","key":"4734_CR60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","volume":"40","author":"RG Thorne","year":"2001","unstructured":"Thorne RG, Frey WH (2001) Delivery of neurotrophic factors to the central nervous system - pharmacokinetic considerations. Clin Pharmacokinet 40(12):907\u2013946. https:\/\/doi.org\/10.2165\/00003088-200140120-00003","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"4734_CR61","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","volume":"29","author":"I Tombacz","year":"2021","unstructured":"Tombacz I, Laczko D, Shahnawaz H et al (2021) Highly efficient CD4+T cell targeting and genetic recombination using engineered CD4+cell-homing mRNA-LNPs. Mol Ther 29(11):3293\u20133304. https:\/\/doi.org\/10.1016\/j.ymthe.2021.06.004","journal-title":"Mol Ther"},{"key":"4734_CR62","doi-asserted-by":"publisher","unstructured":"Van Hoecke L, Roose K (2019) How mRNA therapeutics are entering the monoclonal antibody field. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-019-1804-8","DOI":"10.1186\/s12967-019-1804-8"},{"issue":"7","key":"4734_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/20415990.2024.2363646","volume":"15","author":"J Verma","year":"2024","unstructured":"Verma J, Singh NK, Bansal KK (2024) Recent patents in polymer\u2013lipid hybrid nanoparticles technology. Ther Deliv 15(7):489\u2013493. https:\/\/doi.org\/10.1080\/20415990.2024.2363646","journal-title":"Ther Deliv"},{"key":"4734_CR64","doi-asserted-by":"publisher","unstructured":"Walsh APG, Gordon HN, Peter K (2021) Ultrasonic particles: an approach for targeted gene delivery. Adv Drug Deliv Rev. https:\/\/doi.org\/10.1016\/j.addr.2021.113998","DOI":"10.1016\/j.addr.2021.113998"},{"key":"4734_CR65","doi-asserted-by":"publisher","unstructured":"Wang K, Gao Y, Wu S (2024a) Dual-mRNA delivery using tumor cell lysate-based multifunctional nanoparticles as an efficient colon cancer immunogene therapy. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S452548","DOI":"10.2147\/IJN.S452548"},{"key":"4734_CR66","doi-asserted-by":"publisher","unstructured":"Wang Y, Shen Y, Li J et al (2025) Enhanced RNA secondary structure prediction through integrative deep learning and structural context analysis. Nucleic Acids Res 53(11):gkaf533. https:\/\/doi.org\/10.1093\/nar\/gkaf533","DOI":"10.1093\/nar\/gkaf533"},{"key":"4734_CR67","doi-asserted-by":"publisher","unstructured":"Wang Y, Xu Y, Song J et al (2024b) Tumor cell-targeting and tumor microenvironmentary structure prediction through imultimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer. Int J Nanomedicine:5837\u20135858. https:\/\/doi.org\/10.2147\/IJN.S466042","DOI":"10.2147\/IJN.S466042"},{"key":"4734_CR68","doi-asserted-by":"publisher","unstructured":"Willis E, Pardi N, Parkhouse K et al (2020) Nucleoside-modified mrna vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aav5701","DOI":"10.1126\/scitranslmed.aav5701"},{"issue":"4949 Pt 1","key":"4734_CR69","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P (1990) Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1):1465\u20131468","journal-title":"Science"},{"key":"4734_CR70","doi-asserted-by":"publisher","unstructured":"Wu Y (2024) Large language model and text generation. Natural language processing in biomedicine: a practical guide. Springer International Publishing, Cham, pp 265\u2013297. https:\/\/doi.org\/10.2147\/IJN.S466042","DOI":"10.2147\/IJN.S466042"},{"key":"4734_CR71","doi-asserted-by":"publisher","unstructured":"Yang N, Lai Y, Yu G et al (2025) METTL3-dependent m6A modification of SNAP29 induces \u201cautophagy-mitochondrial crisis\u201d in the ischemic microenvironment after soft tissue transplantation. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2025.2493455","DOI":"10.1080\/15548627.2025.2493455"},{"key":"4734_CR72","unstructured":"Yaworski E, Lam K, Jeffs L, Palmer L, Maclachlan I, inventor; Arbutus Biopharma Corp, assignee (2009) Lipid formulations for nucleic acid delivery patent US11141378B2. Google Patents. https:\/\/patentimages.storage.googleapis.com\/89\/0f\/c3\/d162ad0f7205c6\/US11141378.pdf. Accessed 3 Oct 2025"},{"key":"4734_CR73","doi-asserted-by":"publisher","unstructured":"Yeh TF, Lin C, Sung HC (2023) A review of technological developments in lipid nanoparticle application for mRNA vaccination. Hum Vaccin Immunother 19(2):2256040. https:\/\/doi.org\/10.1080\/21645515.2023.2256040","DOI":"10.1080\/21645515.2023.2256040"},{"key":"4734_CR74","doi-asserted-by":"publisher","unstructured":"Yin Z, Wang S (2024) Enhancing bibliographic reference parsing with contrastive learning and prompt learning. Eng Appl Artif Intell 133:108548. https:\/\/doi.org\/10.1016\/j.engappai.2024.108548","DOI":"10.1016\/j.engappai.2024.108548"},{"issue":"2","key":"4734_CR75","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/all.15111","volume":"77","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li Q, Pan R (2022) Regulatory roles of three miRNAs on allergen mRNA expression in Tyrophagus putrescentiae. Allergy 77(2):469\u2013482. https:\/\/doi.org\/10.1111\/all.15111","journal-title":"Allergy"},{"key":"4734_CR76","doi-asserted-by":"publisher","unstructured":"Zhu Q, Sun J, An C et al (2024) Mechanism of lncRNA Gm2044 in germ cell development. Front Cell Dev Biol 12:1410914. https:\/\/doi.org\/10.3389\/fcell.2024.1410914","DOI":"10.3389\/fcell.2024.1410914"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04734-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04734-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04734-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:08:39Z","timestamp":1775099319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04734-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4734"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04734-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}